The impact of ObamaCare on doctors and patients, companies inside and outside the health sector, and American workers and taxpayers
During the legislative debate over the passage of President Obama’s healthcare law, supporters of the program were sensitive to any suggestion that it represented a government takeover of the healthcare system.
Unless conservatives change their strategy soon, history is likely to record them as the unintended enablers of Obamacare’s expansion. Yet another key moment for a turn toward free-market reform is upon us. Will congressional Republicans again pursue a strategy that sounds serious but results in Obamacare’s unimpeded implementation? Or will they try to actually impede the law in real time and make clear to the American people which party is on their side as we approach 2016?
Senate Majority Leader Mitch McConnell championed a renewed push to bypass a filibuster and repeal Obamacare with 51 votes on Tuesday, he announced in a joint statement with Utah Senator Mike Lee, one of the most conservative Republicans in the chamber.
Neither Republicans nor Democrats have spent much time, at least not in public, discussing changes to the Affordable Care Act (ACA) that could refine or improve the legislation. Republicans have mostly focused on strategies to repeal the ACA, which, even with their control of the House and Senate, appears highly unlikely because they could not muster the 67 votes needed to override a presidential veto. Democrats, while privately acknowledging there are changes that could improve the legislation, have publicly devoted most of their energies to defending the ACA.
After weeks of hemming and hawing on how they’re going to use reconciliation, Senate Republicans finally committed on Tuesday to using the budgetary tool to fully repeal Obamacare.
But it’s what Majority Leader Mitch McConnell did not say in a statement released in conjunction with Sen. Mike Lee that leaves room for things to get interesting: He did not say reconciliation would only be used for a repeal of the Affordable Care Act.
Health and Human Services Secretary Sylvia Burwell said Tuesday that the Government Accountability Office has not told HHS how 11 fictitious applicants were able to maintain coverage as fictitious applicants on Healthcare.gov in an undercover investigation.
“We have asked the GAO in terms of ‘can we understand how you did this, they believe they are protecting their sources and methods,” Burwell said at a House Education and Workforce hearing Tuesday.
In King v. Burwell, Chief Justice John Roberts did the Obama administration a bigger favor than he realized. Writing for a himself and five colleagues, Roberts blessed the administration’s expansion of the Affordable Care Act’s individual mandate, employer mandate, and premium subsidies in the 34 states that refused to establish exchanges — even though the majority, to say nothing of the three dissenters, recognized that expansion was in direct conflict with “the most natural reading of the pertinent statutory phrase.”
FOR FIVE years, Republicans have been trying, unsuccessfully, to repeal Obamacare. But where the GOP has failed, a bipartisan coalition including dozens of Democrats aims to succeed — at least in part. That’s the strange-but-true implication of the new push to repeal the so-called “Cadillac tax” on high-cost employer-paid group health plans.
While the debacle known as ObamaCare has been superseded for the moment by the disastrous Iran nuclear deal and the fireworks in the GOP presidential race, the political battle to repeal this law will continue. Pushed through against popular will by using obscure parliamentary tricks and dispensing old-fashioned “favors” with key lawmakers, ObamaCare has been an unmitigated disaster rife with price hikes, website crashes, lost coverage and corruption.
Several factors are driving employers to private health insurance exchanges, one of the biggest being the 40% excise tax on high cost health care plans set to go into effect in 2018, said Jay Kirschbaum, St. Louis-based senior vice president and practice leader in Willis North America Inc.’s national legal and research group.